Semaglutide – GLP-1 Receptor Agonist (GLP-1R)
Compound Name: Semaglutide
Classification: Research Peptide – Incretin-Related, GLP-1R Agonist
Description:
Semaglutide is a synthetic research peptide classified as a GLP-1 receptor (GLP-1R) agonist. It is widely studied in laboratory research environments for its involvement in metabolic signaling, incretin-related pathways, peptide-mediated receptor activation, and endocrine regulatory processes. Due to its receptor-specific activity and structural properties, Semaglutide is frequently utilized in experimental models focused on metabolic and peptide-signaling research.
COA Downloads:
Disclaimer:
For Laboratory Research Use Only (RUO).
Not for human consumption. Not for therapeutic, diagnostic, or veterinary use.
